Elica S.p.A. (FRA:7L4)
Germany · Delayed Price · Currency is EUR 1.360
+0.010 (0.74%)
At close: Aug 1, 2025, 10:00 PM CET
CTI BioPharma Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | - | 7.87 | 9.78 | 16.61 | 12.12 | -1.79 | Upgrade |
Depreciation & Amortization | - | 20.97 | 21.09 | 20.66 | 22.05 | 22.42 | Upgrade |
Other Amortization | - | 2.04 | 2.63 | 2.87 | 2.78 | 3.02 | Upgrade |
Loss (Gain) From Sale of Assets | - | -7.7 | - | - | - | - | Upgrade |
Asset Writedown & Restructuring Costs | - | -1.15 | 0.14 | - | 3.79 | 2.72 | Upgrade |
Provision & Write-off of Bad Debts | - | 0.88 | -1.23 | -0.79 | 1.06 | - | Upgrade |
Other Operating Activities | - | -0.13 | 2.46 | 12.84 | 19.66 | 5.35 | Upgrade |
Change in Accounts Receivable | - | -9.85 | 25.85 | 35.98 | 5.43 | - | Upgrade |
Change in Inventory | - | 2.46 | 13.89 | -11.65 | -16.57 | - | Upgrade |
Change in Accounts Payable | - | 8.94 | -38.07 | -3.82 | 7.4 | - | Upgrade |
Change in Other Net Operating Assets | - | 0.82 | -9.89 | -29.95 | -5.21 | -11.18 | Upgrade |
Operating Cash Flow | - | 25.13 | 26.65 | 42.74 | 52.51 | 20.53 | Upgrade |
Operating Cash Flow Growth | - | -5.68% | -37.66% | -18.59% | 155.74% | -42.88% | Upgrade |
Capital Expenditures | - | -11.55 | -12.09 | -18.38 | -13.79 | -8.15 | Upgrade |
Cash Acquisitions | - | -0.07 | -6.55 | -11.45 | -9.97 | - | Upgrade |
Sale (Purchase) of Intangibles | - | -5.6 | -4.02 | -4.89 | -9.74 | -5.8 | Upgrade |
Investment in Securities | - | - | - | - | 11.81 | - | Upgrade |
Other Investing Activities | - | - | - | - | - | -1.49 | Upgrade |
Investing Cash Flow | - | -17.21 | -22.66 | -34.71 | -21.7 | -15.43 | Upgrade |
Long-Term Debt Issued | - | 6.33 | - | - | - | 28.01 | Upgrade |
Long-Term Debt Repaid | - | -5.48 | -22.42 | -30.75 | -2.21 | -1.73 | Upgrade |
Net Debt Issued (Repaid) | - | 0.85 | -22.42 | -30.75 | -2.21 | 26.28 | Upgrade |
Repurchase of Common Stock | - | -5.27 | -1.25 | -1.7 | - | - | Upgrade |
Common Dividends Paid | - | -3.09 | -4.38 | -3.77 | - | - | Upgrade |
Other Financing Activities | - | 1.85 | -3.72 | -3.49 | 11.15 | -6.08 | Upgrade |
Financing Cash Flow | - | -5.67 | -31.77 | -39.72 | 8.94 | 20.2 | Upgrade |
Foreign Exchange Rate Adjustments | - | -0.9 | -0.55 | -0.26 | 0.78 | -1.76 | Upgrade |
Miscellaneous Cash Flow Adjustments | - | 0 | - | - | - | - | Upgrade |
Net Cash Flow | - | 1.36 | -28.32 | -31.95 | 40.53 | 23.53 | Upgrade |
Free Cash Flow | - | 13.59 | 14.55 | 24.37 | 38.71 | 12.38 | Upgrade |
Free Cash Flow Growth | - | -6.63% | -40.28% | -37.05% | 212.67% | -46.57% | Upgrade |
Free Cash Flow Margin | - | 2.97% | 3.06% | 4.43% | 7.12% | 2.72% | Upgrade |
Free Cash Flow Per Share | - | 0.22 | 0.23 | 0.39 | 0.61 | 0.20 | Upgrade |
Cash Interest Paid | - | 6.47 | 5.35 | 2.76 | 2.3 | 2.97 | Upgrade |
Cash Income Tax Paid | - | 2.14 | 2.67 | 6.47 | 7.52 | 5 | Upgrade |
Levered Free Cash Flow | - | 15.64 | 3.92 | 12.07 | 54.09 | 0.08 | Upgrade |
Unlevered Free Cash Flow | - | 19.62 | 7.04 | 13.6 | 55.49 | 2.03 | Upgrade |
Change in Net Working Capital | - | -10.86 | 13.9 | 7.08 | -35.86 | 19.23 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.